Clinical trial
The Adult Antiretroviral Treatment and Resistance Study (Tshepo)
NCT00197613 is registered in ClinicalTrials.gov with Harvard School of Public Health (HSPH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Adult Antiretroviral Treatment and Resistance Study (Tshepo)
- Lead sponsor
- Harvard School of Public Health (HSPH)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2002
- Completion date
- December 31, 2007
- Enrollment
- 650
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aids, hiv infection